UNSPSC 51294501: Ivoqualine

This classification denotes an antidepressant agent with the molecular formula C20H26N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W0K2QLU43U, chemically known as 6-methoxy-4-(3-((3s,4r)-3-vinyl-4-piperidyl)propyl)quinoline. but generally known as ivoqualine, which bears US NIH Compound Identifier 3038482. European Medicines Agency schedules Ivoqualine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08359MIG.

UNSPSC 51294501 Ivoqualine is a Commodity code that captures pharmaceutical products and medical supplies procured by state and local health agencies, though the single recent opportunity in the dataset shows a mismatch between the code's nominal scope and actual procurement activity. Seminole County, Florida posted an IFB for Naloxone and Safe Drug Deactivation Systems—emergency response and harm-reduction supplies rather than ivoqualine itself. The opportunity calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their bids, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract spans an initial two-year term with a one-year renewal option and includes a three-month probationary period permitting termination at will. The procurement is potentially FEMA-funded, introducing additional compliance obligations including adherence to the Clean Air Act and Federal Water Pollution Control Act.

The code shows minimal recent state and local activity aligned with its nominal definition. The single tracked opportunity—Seminole County's IFB 60459723LAS posted June 30, 2026, with a response deadline of July 26, 2023—addresses naloxone procurement rather than ivoqualine, suggesting that state and local procurement offices may be applying this code inconsistently or that ivoqualine itself sees limited activity in state and local markets. Geographic coverage is limited to Florida in the recent dataset. Vendors pursuing this code should clarify with issuing agencies whether their actual product or service aligns with the code assignment before investing in proposal development.